Silver

Silver

SCHEMBL555009

CC(C)(C)OP(=O)([O-])OC(C)(C)C.[Ag+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7860312 0.94
Potassium Ion SCHEMBL553768 0.94 SLC34A1 (0.32)
SCHEMBL920065 0.94
SCHEMBL4823616 0.94
Lithium Ion SCHEMBL21749348 0.94
SCHEMBL553542 0.94
Water SCHEMBL28672424 0.91 SLC34A1 (0.30)
Tetramethylammonium Ion SCHEMBL1758243 0.88
Potassium Ion SCHEMBL18394942 0.75 SLC34A1 (0.32)
Lithium Ion SCHEMBL21749343 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108456194-B Triazole antibacterial derivative, and pharmaceutical composition and application thereof 武汉朗来科技发展有限公司 2021-06-22 CN disclosed
US-11040958-B2 Triazole antimicrobial derivative, pharmaceutical composition and use thereof WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2021-06-22 US disclosed
CN-107033186-B Posaconazole derivatives, pharmaceutical compositions and uses thereof 武汉朗来科技发展有限公司 2020-06-09 CN disclosed
US-20190038621-A1 POSACONAZOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2019-02-07 US disclosed
CN-105367482-B N acyl sulfonamides apoptosis accelerator 阿斯利康(瑞典)有限公司 2017-12-12 CN disclosed
US-20160176906-A1 Chemical Compounds ASTRAZENECA AB (SE) 2016-06-23 US disclosed
CN-105367482-A N-acylsulfamide apoptosis accelerator ASTRAZENECA AB 2016-03-02 CN disclosed
US-9248140-B2 Chemical compounds ASTRAZENECA AB (SE) 2016-02-02 US disclosed
CN-103153954-B N-acylsulfonamide apoptosis promoters ASTRAZENECA AB (SE) 2015-11-25 CN disclosed
US-20150328239-A1 Chemical Compounds ASTRAZENECA AB (SE) 2015-11-19 US disclosed
WO-2002042283-A1 IMPROVED PROCESS FOR WATER SOLUBLE AZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-05-30 WO disclosed
US-20020062028-A1 Process for water soluble azole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2002-05-23 US disclosed
US-6362172-B2 (DIHYDROGEN PHOSPHONOXY)ALKYLOXY CONTAINING A TRIAZOLE DERIVATIVE USED AS ANTIFUNGAL AGENT BRISTOL-MYERS SQUIBB COMPANY 2002-03-26 US disclosed
US-20010041691-A1 Water soluble prodrugs of azole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2001-11-15 US disclosed
US-20010016662-A1 Water-soluble prodrugs of azole compounds GOLIK JERZY (US) 2001-08-23 US disclosed
US-20010014742-A1 Water-soluble prodrugs of azole compounds GOLIK JERZY (US) 2001-08-16 US disclosed
WO-2001052852-A1 WATER SOLUBLE PRODRUGS OF AZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-07-26 WO disclosed
US-6235728-B1 FUNGICIDES BRISTOL-MYERS SQUIBB COMPANY 2001-05-22 US disclosed
US-5310648-A Polymer-metal chelate compound CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1994-05-10 US disclosed
WO-1992013447-A1 TEMPLATE POLYMERIZATION USING METAL CHELATES AND FLUID IMPRINT MATRICES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1992-08-20 WO disclosed